{"id":"W2976039904","doi":"10.1016/j.jalz.2019.07.010","title":"Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?","year":2019,"lang":"en","type":"review","venue":"Alzheimer s & Dementia","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Johnson and Johnson Pharmaceutical Research and Development; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Genentech; H. Lundbeck A/S; Servier; Takeda Pharmaceutical Company; Department for International Development; BioClinica; Biogen; Pfizer; Novartis Pharmaceuticals Corporation; Meso Scale Diagnostics; Medical Research Council; Eli Lilly and Company; Bristol-Myers Squibb; GE Healthcare; Alzheimer's Association; Fujirebio US; Department for International Development, UK Government; Roche; Merck; Alzheimer's Drug Discovery Foundation; National Institute on Aging","keywords":"Disease; Alzheimer's disease; Neuroimaging; Alzheimer's Disease Neuroimaging Initiative; Psychology; Perspective (graphical); Biomarker; Clinical trial; Neuroscience; Medicine; Cognitive psychology; Pathology; Artificial intelligence; Biology; Computer science","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01384804,0.0009358998,0.003477631,0.002055018,0.0005014617,0.002923501,0.002411722,0.005274225,0.004300135],"category_scores_gemma":[0.03730228,0.0003859067,0.001285664,0.002233105,0.003775241,0.00573216,0.001348327,0.009951469,0.002230947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001836708,"about_ca_system_score_gemma":0.005146846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002366105,"about_ca_topic_score_gemma":0.003508003,"domain_scores_codex":[0.9966203,0.001814693,0.0004924224,0.0004380274,0.0005326351,0.0001018999],"domain_scores_gemma":[0.9718314,0.02058636,0.001758952,0.0005640011,0.004751366,0.0005078643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004306929,0.00006966197,0.0006412548,0.04277606,0.0006311271,0.0002934119,0.0004959762,0.0004832392,0.0006044291,0.08763089,0.2222132,0.64373],"study_design_scores_gemma":[0.0001633778,0.0002296941,0.001261262,0.0488876,0.0005718085,0.00119186,0.0005679782,0.0002522522,0.000205538,0.08447046,0.8621204,0.00007774122],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001213997,0.9268187,0.0005417392,0.06465439,0.006925202,0.00001213599,0.00006141643,0.000009174234,0.0008558604],"genre_scores_gemma":[0.004228692,0.9227445,0.001176355,0.05250254,0.01848158,0.00005941831,0.0000954185,0.00001261549,0.0006989427],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01384804,"threshold_uncertainty_score":0.07323635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1683059895636867,"score_gpt":0.435874934429663,"score_spread":0.2675689448659764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}